Only 13 randomized trials inform radiotherapy for cutaneous malignancies, systematic review finds
Across cutaneous malignancies, only 13 randomized RT trials enrolled fewer than 2,500 patients, leaving major gaps in contemporary treatment evidence.
Across cutaneous malignancies, only 13 randomized RT trials enrolled fewer than 2,500 patients, leaving major gaps in contemporary treatment evidence.
None of four selected blood-biomarker domains currently supports treatment personalization, and sampling schedules frequently failed to match expected biological kinetics.